Performance, Efficacy, and Safety of Lubiprostone in Bowel Preparation Regimens
Lubiprostone as an adjunct agent for bowel prep improves the odds of excellent quality prep while mitigating the odds of poor prep. Lubiprostone adjunct bowel prep is similar to control in adverse effects.
Authors
- Kyle S. Liu (ORCID: https://orcid.org/0000-0003-3747-4421)
- Manuel Garza
- Daryl Ramai
- Joseph Gung
- Andrew Han (ORCID: https://orcid.org/0000-0002-9283-3725)
- Aline Ghaleb
- Yizhong Wu
- Alexander Grieme
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Washington University in St. Louis (US)
- Baylor Medical Center at Garland (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1097/mcg.0000000000002215
- Citations
- 1
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 1.05